Market Value10,823,762,000
Total Holdings133
File Date2015-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MGNX / MacroGenics, Inc.
GBT / Global Blood Therapeutics Inc.
CERS / Cerus Corporation
KYTH / Kythera Biopharma
VTAE / Vitae Pharmaceuticals, Inc.
AERI / Aerie Pharmaceuticals Inc
ABUS / Arbutus Biopharma Corporation
BLPH / Bellerophon Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
NLTX / Neoleukin Therapeutics, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
IRWD / Ironwood Pharmaceuticals, Inc.
FMI / Foundation Medicine, Inc.
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
ABBV / AbbVie Inc.
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
PTN / Palatin Technologies, Inc.
JUNO / Juno Therapeutics, Inc.
NBRV / Nabriva Therapeutics Plc
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
WINT / Windtree Therapeutics, Inc.
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
0HBB / Aimmune Therapeutics Inc
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
PRQR / ProQR Therapeutics N.V.
NDRM / NeuroDerm Ltd.
MDWD / MediWound Ltd.
ECYT / Endocyte, Inc.
IMDZ / Immune Design Corp.
30161QAC8 / Exelixis, Inc. Bond
Arrowhead Research Corp. / (042797209)
OSIR / Osiris Therapeutics, Inc.
451731103 / Ignyta, Inc.
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
OMER / Omeros Corporation
CNCE / Concert Pharmaceuticals Inc
ARCT / Arcturus Therapeutics Holdings Inc.
XNPT / XenoPort, Inc.
NBSE / NeuBase Therapeutics, Inc.
LGND / Ligand Pharmaceuticals Incorporated
SVRA / Savara Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
ONCE / Spark Therapeutics, Inc.
DSCI / Derma Sciences, Inc.
MDVN / Medivation, Inc.
RCPT / Receptos, Inc.
CYTR / LadRx Corp
032420101 / Anacor Pharmaceuticals, Inc.
HALO / Halozyme Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
BCRX / BioCryst Pharmaceuticals, Inc.
IDRA / Idera Pharmaceuticals, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
TRIL / Trillium Therapeutics Inc
SGMO / Sangamo Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
STML / Stemline Therapeutics, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
GHDX / Genomic Health, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
ZIOP / Alaunos Therapeutics Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
76028H209 / Repros Therapeutics, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
CLVS / Clovis Oncology Inc
VXRT / Vaxart, Inc.
DYAX / Dyax Corp.
DERM / Journey Medical Corporation
XOMA / XOMA Royalty Corporation
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
BDSI / Biodelivery Sciences International
MCRB / Seres Therapeutics, Inc.
INSM / Insmed Incorporated
/ Achaogen Inc
US189464AB64 / Clovis Oncology, Inc. 2.5% 9/15/2021
ITCI / Intra-Cellular Therapies, Inc.
GILD / Gilead Sciences, Inc.
INCY / Incyte Corporation
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
EPZM / Epizyme Inc
KPTI / Karyopharm Therapeutics Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
CMRX / Chimerix, Inc.
LOXO / Loxo Oncology, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
AUPH / Aurinia Pharmaceuticals Inc.
/ Array BioPharma, Inc.
ISEE / IVERIC bio Inc
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
US33830X1046 / Five Prime Therapeutics Inc
APTO / Aptose Biosciences Inc.
IONS / Ionis Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
MTEM / Molecular Templates, Inc.
ALDX / Aldeyra Therapeutics, Inc.
LJPC / La Jolla Pharmaceutical Co.
ACAD / ACADIA Pharmaceuticals Inc.
QLGN / Qualigen Therapeutics, Inc.
SRRA / Sierra Oncology Inc
ACOR / Acorda Therapeutics, Inc.
CRIS / Curis, Inc.
CCXI / ChemoCentryx Inc
TENX / Tenax Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
VNDA / Vanda Pharmaceuticals Inc.
NVAX / Novavax, Inc.
TRVN / Trevena, Inc.
TARA / Protara Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
BLUE / bluebird bio, Inc.
DVAX / Dynavax Technologies Corporation
LIFE / aTyr Pharma, Inc.
IMGN / ImmunoGen, Inc.
BMRN / BioMarin Pharmaceutical Inc.
SAGE / Sage Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
RARE / Ultragenyx Pharmaceutical Inc.
AFMD / Affimed N.V.
XNCR / Xencor, Inc.
NTRA / Natera, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
ARAV / Aravive, Inc.
ASMB / Assembly Biosciences, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
HRTX / Heron Therapeutics, Inc.
NVTA / Invitae Corporation